Merriman Curhan Ford downgrades Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX) from Buy to Neutral. Fair value range between $32-39.

Merriman analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE